These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23988330)

  • 1. Safety mechanism assisted by the repressor of tetracycline (SMART) vaccinia virus vectors for vaccines and therapeutics.
    Grigg P; Titong A; Jones LA; Yilma TD; Verardi PH
    Proc Natl Acad Sci U S A; 2013 Sep; 110(38):15407-12. PubMed ID: 23988330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication-inducible vaccinia virus vectors with enhanced safety in vivo.
    O'Connell CM; Jasperse B; Hagen CJ; Titong A; Verardi PH
    PLoS One; 2020; 15(4):e0230711. PubMed ID: 32240193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication.
    Hagen CJ; Titong A; Sarnoski EA; Verardi PH
    Virus Res; 2014 Mar; 181():43-52. PubMed ID: 24394294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses.
    Holechek SA; Denzler KL; Heck MC; Schriewer J; Buller RM; Legrand FA; Verardi PH; Jones LA; Yilma T; Jacobs BL
    PLoS One; 2013; 8(10):e77879. PubMed ID: 24147092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenic.
    Verardi PH; Legrand FA; Chan KS; Peng Y; Jones LA; Yilma TD
    J Interferon Cytokine Res; 2014 Mar; 34(3):169-78. PubMed ID: 24168450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective reconstitution of IFN‑γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infection.
    Borst K; Flindt S; Blank P; Larsen PK; Chhatbar C; Skerra J; Spanier J; Hirche C; König M; Alanentalo T; Hafner M; Waibler Z; Pfeffer K; Sexl V; Sutter G; Müller W; Graalmann T; Kalinke U
    PLoS Pathog; 2020 Feb; 16(2):e1008279. PubMed ID: 32023327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.
    Earl PL; Americo JL; Moss B
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28747505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved safety of a replication-competent poxvirus-based HIV vaccine with the introduction of the HSV-TK/GCV suicide gene system.
    Zhang Q; Liu Z; Hou J; Wang S; Liu C; Wei M; Liu Y; Shao Y
    Vaccine; 2016 Jun; 34(30):3447-53. PubMed ID: 27195760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.
    Clark KM; Johnson JB; Kock ND; Mizel SB; Parks GD
    Virology; 2011 Oct; 419(2):97-106. PubMed ID: 21885079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
    Chen NG; Yu YA; Zhang Q; Szalay AA
    J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system.
    Ho DY; McLaughlin JR; Sapolsky RM
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):200-9. PubMed ID: 8883953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination.
    Vijaysri S; Jentarra G; Heck MC; Mercer AA; McInnes CJ; Jacobs BL
    Vaccine; 2008 Jan; 26(5):664-76. PubMed ID: 18096276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors.
    Schmeisser F; Donohue M; Weir JP
    Hum Gene Ther; 2002 Dec; 13(18):2113-24. PubMed ID: 12542843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo.
    Legrand FA; Verardi PH; Chan KS; Peng Y; Jones LA; Yilma TD
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2940-5. PubMed ID: 15705716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.
    Verardi PH; Titong A; Hagen CJ
    Hum Vaccin Immunother; 2012 Jul; 8(7):961-70. PubMed ID: 22777090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional expression of vaccinia virus genes in mammalian cell lines expressing the tetracycline repressor.
    Hedengren-Olcott M; Hruby DE
    J Virol Methods; 2004 Sep; 120(1):9-12. PubMed ID: 15234804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling.
    Price PJ; Torres-Domínguez LE; Brandmüller C; Sutter G; Lehmann MH
    Vaccine; 2013 Sep; 31(39):4231-4. PubMed ID: 23523404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetracycline-inducible promoter-based conditionally replicative adenoviruses for the control of viral replication.
    Zhang H; Takayama K; Zhang L; Uchino J; Harada A; Harada T; Hisasue J; Nakagaki N; Zhou C; Nakanishi Y
    Cancer Gene Ther; 2009 May; 16(5):415-22. PubMed ID: 19148207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly efficient regulation of gene expression by tetracycline in a replication-defective herpes simplex viral vector.
    Yao F; Theopold C; Hoeller D; Bleiziffer O; Lu Z
    Mol Ther; 2006 Jun; 13(6):1133-41. PubMed ID: 16574491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.